Neolook achieved MDR Class I CE certification for both Neolook One – its clinical bedside monitoring platform – and Neolook Mira – its family connection system – under a single ISO 13485-structured QMS in 2026, establishing the only CE MDR-certified integrated clinical and family monitoring system available from a single provider across the European Economic Area.
The position was validated by the market immediately: three independent competitive evaluations – NWZ Noordwest Alkmaar (Netherlands), Rotunda (Ireland) and Policlinico di Milano (Italy) – selected Neolook over alternatives, with hospital procurement teams explicitly citing the single-source CE MDR position as the deciding factor.
No competitor in the EU neonatal monitoring segment offers both clinical bedside monitoring and family connection under one CE MDR umbrella and one QMS. This capstone closes the Neolook One bedside-to-breakthrough cycle and establishes the dual-certified integrated platform as a structural market access moat across all 27 EU member states.